Andreas D.
- Country
- Germany
- Department
- Klinik für Hals,-Nasen- und Ohrenheilkunde
Research Overview
- Efficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Evaluation of BI 770371 and Pembrolizumab, With or Without Cetuximab, Versus Pembrolizumab Monotherapy in Head and Neck Squamous Cell Carcinoma Patients
- Long‑Term Safety and Tolerability of Subcutaneous Itepekimab in Adults with Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyps: Double‑Blind Extension Study
Data & Insights
Has run more than one trial at 150 of 313 partner sites.
Specializations
Head and Neck Cancer Treatment
Specializes in advanced therapeutic approaches for head and neck squamous cell carcinoma (HNSCC), with particular focus on laryngeal and hypopharyngeal cancers. Investigates innovative organ preservation strategies and immunotherapy combinations.
- Larynx preservation protocols
- HPV-positive oropharyngeal cancer management
- Immunotherapy integration
Explores novel treatment combinations for both localized and metastatic disease states.
Immunotherapy Research
Conducts extensive research in immune checkpoint inhibition and novel immunotherapy combinations for head and neck cancers. Focuses on PD-1/PD-L1 targeted therapies and innovative immunological approaches.
- Checkpoint inhibitor combinations
- Novel immunotherapy agents
- Biomarker-driven treatment selection
Evaluates treatment efficacy in both HPV-related and HPV-unrelated cancers.
Rhinosinusitis Studies
Investigates therapeutic solutions for chronic rhinosinusitis, including both polyp and non-polyp variants. Explores novel biological treatments and targeted therapies for nasal conditions.
- Nasal polyp management
- Anti-inflammatory treatments
- Symptom control strategies
Focuses on improving patient outcomes through innovative medical interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.